Cargando…
Genomic characterization of high-risk non-muscle invasive bladder cancer
The genetic mechanisms associated with progression of high-risk non-muscle-invasive bladder cancer (HR-NMIBC) have not been described. We conducted selective next-generation sequencing (NGS) of HR-NMIBC and compared the genomic profiles of cancers that responded to intravesical therapy and those tha...
Autores principales: | Meeks, Joshua J., Carneiro, Benedito A., Pai, Sachin G., Oberlin, Daniel T., Rademaker, Alfred, Fedorchak, Kyle, Balasubramanian, Sohail, Elvin, Julia, Beaubier, Nike, Giles, Francis J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342732/ https://www.ncbi.nlm.nih.gov/pubmed/27750214 http://dx.doi.org/10.18632/oncotarget.12661 |
Ejemplares similares
-
Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials
por: Costa, Ricardo, et al.
Publicado: (2016) -
A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer
por: Fantini, Damiano, et al.
Publicado: (2018) -
Trimodality Treatment for Muscle-Invasive Bladder Cancer: An Institutional Experience
por: Polineni, Praneet, et al.
Publicado: (2021) -
Changes in Lean Muscle Mass Associated with Neoadjuvant Platinum-Based Chemotherapy in Patients with Muscle Invasive Bladder Cancer
por: Rimar, Kalen J., et al.
Publicado: (2018) -
Organ-Sparing Strategies in Muscle-Invasive Bladder Cancer
por: Witjes, J Alfred, et al.
Publicado: (2021)